Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.
作者信息
Riddle Matthew C
机构信息
Oregon Health and Science University, L-345, 3181 SW Sam Jackson Park Rd, Portland, OR 97239-3098, USA.
出版信息
Circulation. 2010 Aug 24;122(8):844-6. doi: 10.1161/CIRCULATIONAHA.110.960138.
Abstract
摘要
相似文献
1
Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.糖尿病控制心血管风险行动（ACCORD）试验中强化降糖对2型糖尿病患者治疗的影响。
Circulation. 2010 Aug 24;122(8):844-6. doi: 10.1161/CIRCULATIONAHA.110.960138.
2
[Intensive glycemia control of type-2 diabetes mellitus: a real A(D)VANCe or a deep dis(ACCORD)?].[2型糖尿病强化血糖控制：是真正的进展还是深度的不协调？]
Rev Med Suisse. 2008 Aug 6;4(166):1734.
3
Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial--clinical implications.糖尿病心血管风险控制行动（ACCORD）试验——临床意义
Clin Chem. 2011 Feb;57(2):261-3. doi: 10.1373/clinchem.2010.148288. Epub 2010 Oct 25.
4
Diabetes. Insights from the extended follow-up of the ACCORD trial.糖尿病。ACCORD 试验延长随访的见解。
Nat Rev Cardiol. 2011 Jun;8(6):308-10. doi: 10.1038/nrcardio.2011.65. Epub 2011 Apr 19.
5
Clinical research. Deaths in diabetes trial challenge a long-held theory.临床研究。糖尿病试验中的死亡案例对一个长期持有的理论提出了挑战。
Science. 2008 Feb 15;319(5865):884-5. doi: 10.1126/science.319.5865.884.
6
7
Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies.2型糖尿病中的心血管疾病与强化血糖控制：推动实践走向基于证据的策略
Vasc Health Risk Manag. 2009;5:859-71. doi: 10.2147/vhrm.s4808. Epub 2009 Nov 2.
8
Why are we doing cardiovascular outcome trials in type 2 diabetes?我们为什么要在2型糖尿病患者中开展心血管结局试验？
Cleve Clin J Med. 2014 Nov;81(11):665-71. doi: 10.3949/ccjm.81gr.14005.
9
[Acute blood sugar peaks endanger blood vessels: the postprandial situation to be controlled better].急性血糖峰值危及血管：餐后情况需更好控制
MMW Fortschr Med. 2006 Jun 29;148(26):57.
10
Diabetes control among Hispanics in the action to control cardiovascular risk in diabetes trial.在糖尿病行动控制心血管风险试验中西班牙裔的糖尿病控制情况。
J Gen Intern Med. 2012 Nov;27(11):1499-505. doi: 10.1007/s11606-012-2131-4. Epub 2012 Jun 29.
引用本文的文献
1
Genetic evidence for T-wave area from 12-lead electrocardiograms to monitor cardiovascular diseases in patients taking diabetes medications.从 12 导联心电图的 T 波面积获取遗传证据，以监测服用糖尿病药物的患者的心血管疾病。
Hum Genet. 2024 Oct;143(9-10):1095-1108. doi: 10.1007/s00439-024-02661-6. Epub 2024 Mar 20.
2
Towards a better understanding of arterial calcification disease progression in CKD: investigation of early pathological alterations.为了更好地了解 CKD 中的动脉钙化疾病进展：对早期病理改变的研究。
Nephrol Dial Transplant. 2023 May 4;38(5):1127-1138. doi: 10.1093/ndt/gfac301.
3
New Hypoglycemic Drugs: Combination Drugs and Targets Discovery.新型降糖药物：复方制剂与靶点发现
Front Pharmacol. 2022 Jun 8;13:877797. doi: 10.3389/fphar.2022.877797. eCollection 2022.
4
Significant reduction in chronic kidney disease progression with sodium-glucose cotransporter-2 inhibitors compared to dipeptidyl peptidase-4 inhibitors in adults with type 2 diabetes in a UK clinical setting: An observational outcomes study based on international guidelines for kidney disease.在英国临床环境中，与二肽基肽酶-4 抑制剂相比，钠-葡萄糖共转运蛋白-2 抑制剂可显著减少 2 型糖尿病成人的慢性肾脏病进展：基于肾脏病国际指南的观察性结局研究。
Diabetes Obes Metab. 2022 Nov;24(11):2138-2147. doi: 10.1111/dom.14799. Epub 2022 Jul 6.
5
Not Control but Conquest: Strategies for the Remission of Type 2 Diabetes Mellitus.非控制而是征服：2型糖尿病缓解策略
Diabetes Metab J. 2022 Mar;46(2):165-180. doi: 10.4093/dmj.2021.0377. Epub 2022 Mar 24.
6
Variety of Cardiac Events in Hospitalized Chronic Kidney Disease Patients.住院慢性肾脏病患者的心脏事件种类
Cureus. 2021 Oct 15;13(10):e18801. doi: 10.7759/cureus.18801. eCollection 2021 Oct.
7
The Role of Dapagliflozin in the Management of Heart Failure: An Update on the Emerging Evidence.达格列净在心力衰竭管理中的作用：新证据更新
Ther Clin Risk Manag. 2021 Aug 12;17:823-830. doi: 10.2147/TCRM.S275076. eCollection 2021.
8
A Type 2 Diabetes Subtype Responsive to ACCORD Intensive Glycemia Treatment.对 ACCORD 强化血糖治疗有反应的 2 型糖尿病亚型。
Diabetes Care. 2021 Jun;44(6):1410-1418. doi: 10.2337/dc20-2700. Epub 2021 Apr 16.
9
Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options.慢性肾脏病中的心血管疾病：病理生理学见解与治疗选择。
Circulation. 2021 Mar 16;143(11):1157-1172. doi: 10.1161/CIRCULATIONAHA.120.050686. Epub 2021 Mar 15.
10
Association Between Lipoprotein(a) and Peri-procedural Myocardial Infarction in Patients With Diabetes Mellitus Who Underwent Percutaneous Coronary Intervention.脂蛋白(a)与糖尿病患者经皮冠状动脉介入治疗后围术期心肌梗死的关系。
Front Endocrinol (Lausanne). 2021 Feb 3;11:603922. doi: 10.3389/fendo.2020.603922. eCollection 2020.
本文引用的文献
1
Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial.ACCORD 试验中血糖治疗中位 3.4 年随访期间 A1C 与全因死亡率的流行病学关系。
Diabetes Care. 2010 May;33(5):983-90. doi: 10.2337/dc09-1278.
2
Determinants of severe hypoglycemia complicating type 2 diabetes: the Fremantle diabetes study.影响 2 型糖尿病患者发生严重低血糖的因素：弗里曼特尔糖尿病研究。
J Clin Endocrinol Metab. 2010 May;95(5):2240-7. doi: 10.1210/jc.2009-2828. Epub 2010 Mar 19.
3
Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.强化血糖控制与标准血糖治疗策略对不同基线亚组特征患者死亡率的影响：心血管风险控制行动中的糖尿病（ACCORD）试验。
Diabetes Care. 2010 Apr;33(4):721-7. doi: 10.2337/dc09-1471. Epub 2010 Jan 26.
4
Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia.反复发作的中度低血糖可改善严重低血糖引起的脑损伤和认知功能障碍。
Diabetes. 2010 Apr;59(4):1055-62. doi: 10.2337/db09-1495. Epub 2010 Jan 19.
5
The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study.基线特征、血糖治疗方法和糖化血红蛋白浓度对严重低血糖风险的影响：ACCORD 研究的事后流行病学分析。
BMJ. 2010 Jan 8;340:b5444. doi: 10.1136/bmj.b5444.
6
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study.2 型糖尿病患者症状性、严重低血糖与死亡的相关性：ACCORD 研究的回顾性流行病学分析。
BMJ. 2010 Jan 8;340:b4909. doi: 10.1136/bmj.b4909.
7
Effects of intensive glucose lowering in type 2 diabetes.强化降糖对2型糖尿病的影响。
N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6.
8
Glycemia treatment strategies in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial.糖尿病心血管风险控制行动（ACCORD）试验中的血糖治疗策略。
Am J Cardiol. 2007 Jun 18;99(12A):34i-43i. doi: 10.1016/j.amjcard.2007.03.004. Epub 2007 Apr 19.
9
Association of hypoglycemia and cardiac ischemia: a study based on continuous monitoring.低血糖与心脏缺血的关联：一项基于连续监测的研究
Diabetes Care. 2003 May;26(5):1485-9. doi: 10.2337/diacare.26.5.1485.
10
Frequency of severe hypoglycemia requiring emergency treatment in type 1 and type 2 diabetes: a population-based study of health service resource use.1型和2型糖尿病患者中需要急诊治疗的严重低血糖发生率：一项基于人群的卫生服务资源利用研究
Diabetes Care. 2003 Apr;26(4):1176-80. doi: 10.2337/diacare.26.4.1176.
Zotero 插件